# TREMFYA

NDC: 57894-650
Generic name: Guselkumab
Labeler / Manufacturer: Janssen Biotech, Inc.
Product type: HUMAN PRESCRIPTION DRUG
Marketing category: Biologic License Application
Dosage form: INJECTION
Routes: INTRAVENOUS
Marketing started: 20240911

FDA application: BLA761061

## Active ingredients

- GUSELKUMAB: 200 mg/20mL

## Pharmacological class

—

## External sources

- openFDA: https://api.fda.gov/drug/ndc.json?search=product_ndc:"57894-650"
- FDA NDC Directory: https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=57894-650
- DailyMed: https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=1e6dc9ae-1c4c-42d9-87aa-c315ecc51b56